Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial
Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page now displays the study record for velaglucerase alfa in patients with type 1 Gaucher disease, including its treatment details, participation criteria, and locations.SummaryDifference47%

- Check9 days agoChange DetectedThe site footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA general NIH notice about website changes and terminology appears above the ClinicalTrials.gov error page, and the displayed revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study page now shows a 403 Forbidden error. It replaces the previous study details with a standard error layout and a Home button.SummaryDifference16%

- Check58 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a frontend or template update for the study record rather than changes to the study data. The update reflects a UI or system adjustment rather than edits to the clinical information on the page.SummaryDifference0.1%

Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.